Skip to main content
. 2021 May 12;20(3):277–288. doi: 10.1002/rmb2.12380

TABLE 3.

Transplantation details and outcomes for Group 1 (tissue frozen at our institution)

Patient No. Volume tissue grafted (mm3) Follicle density (follicle/mm2) Time to resumption (mo) Duration of function (mo) Treatment details
1 84/168 14.3 7/3 18/65 Ceased treatment
2 531 1.8 5 9+ In treatment
4 160/155 5.7 7/1 10/4+ In treatment
6 545 1.1 1 14+ In treatment
8 405 6.7 3.0 2+ In treatment
9 255 4.5 4 12+ Ongoing pregnancy
10 295/150 7.6 4 39/— Ceased treatment
11 60 1.9 7 2 Ceased treatment
12 430/675 0.3 5 9+/— In treatment
13 440 2.0 4 5 In treatment
14 575 1.3 5 11+ Ceased treatment
16 240 0.7 4.3 7+ In treatment
17 270 2.2 5 10 In treatment
20 125/250 0.1 5/— 13/— Ceased treatment
21 243 1.6 5 9 In treatment
22 404/295 5.4 3/1 12/20+ In treatment
23 170/280 0.6 6/5 2/6+ Ceased treatment
24 250/295 5.5 5/3 12/29 In treatment
25 205/235 1.4 5/— 36/— Ceased treatment
26 170 7.5 4 9 Passed away
27 450 2.2 5.4 6+ In treatment
28 235 0.6 4 16 Loss to follow‐up
30 410/350 0.2 2/4 6/— In treatment
31 240 3.9 5.3 6+ In treatment
33 387 0.7 2 14 Ceased treatment
34 160/170 0.2 9/— 1/— In treatment
35 270 6.4 4 22+ In treatment
36 260/305 7.5 3/1 29/— Loss to follow up
40 315 0.2 6.3 1 In treatment